专利摘要:
L-Carnitine is prepared from crotonic betaine and/or gamma -butyric betaine by microbiological means.
公开号:SU1435159A3
申请号:SU853874110
申请日:1985-03-28
公开日:1988-10-30
发明作者:Кулла Ханс;Лехки Павел
申请人:Лонца Аг. (Фирма);
IPC主号:
专利说明:

WITH
4 00
ate
ate
with

cm
This invention relates to biotechnology and relates to the production of L-carnitine.
The aim of the invention is to develop an L-carnitine yield.
The method is as follows.
The proposed microorganisms are able to produce L-carnitine from crotonobetaine or -y-butyrobetaine, which does not decompose the latter. All these microorganisms can be producers with the proviso that they are mutated according to the following two-step method of selection,
a) microorganisms that grow a1 b | 1e on betaine, u-butyrobetaine, crotonobetine and L-carnitine as a source of carbon and nitrogen are mutated by known methods;
b) from a culture of mutated organisms obtained as a result of the cultivation process, selection is made of resistant microorganisms that do not decompose b-carnitine and are non-destructive; on betaine, krotobetatsne,
. tirobetaine. Expansion 1 (straining of strains, stretching x on betaine, crotonobetaine.
Description of Oggamma Agrobacterium HK 4 (DSM No. 2938):

at
 ,
condition

Mac-ss id
sticks partially pleomorphic
1-2 0.5-0.8
+,
peritrichus
y-butyrobetaine as a source of carbon and nitrogen, carry out nutrient solutions by sowing a mixture of bacteria on crotonoeyanogen, prepare mixed cultures in this way, and then, using traditional microbiological techniques, pure cultures of microbe-decomposing betaine are obtained. The mutation of cultures growing on y-butyrobetaine, crotonobetaine as a source of nitrogen and carbon is carried out by known methods. Thus mutated microorganisms are selected
The microorganism growing on butyrobetaine or crotonobetaine as a source of carbon and nitrogen is pgamm NK 4 (DSM 2938) and its descendants and mutants. This strain of 03/03/84 for P DSM 2938 was deposited with Neme1C (th collection of microorganisms (Deutsche A.Sanmluitg von Mikroorganismen (DSM) under Gesellschaft fiir Biotechnologische Forschung mbH, Griesebachstrabe, 8 4300 Gottingen, phPG).
Formation of phenylalanine deaminase ornithine decarboxylase
Proscower
nitrate +
+



+
+
substrate
Pigments
non diffusible diffusible. Fluorescent Acid Formation (OF test) from glucose
anaerobically
fructose aerobic - ASS glucose + xylose
trehalose +
ethanolGas production from glucose
ONPG +
Education
arginine digase lysine decarboxylase 6 by copogenism, resulting from mutation and selection from this microorganism, which is resistant, does not. decomposes L-carnitine, and grows on it and grows on croton vetaineum or - butyrobetaine, is Agrobacteriura NC 13 strain.
Description strain Agrobactererium NK 13 (DSM No. 2903)

at
at

condition
Mas
SS ohm agar
sticks
partially
pleomorphic
1-2 0.5-0.8
+
peritrichus
+ +

+
+ +
Autotrophic growth on Hj 3-ketolactose
Growth on betaine b-carnitine v-butyrobetaine crotonobetaine
strain 01/23/84 was transferred to Gesellschaft fOr Biotechnologische Torsehung mbH, briesebachstrabe 8, - 4300 Gettingen, Germany, deposited under No. DSM 2903 in the Deutsche collection 8 rung von Mikroorganismen (DSM).
Education
phenylalanine deaminase - ornithine decarboxyCylase H-zS
Reaction Voges-Pr
Education
indolanitrite from none
Denitrification
Levan's education
lecithinaseurease
Degradation
starch; gelatin caseinatyrosinatin 80 esculin DNA
Continuation count
Pigments
non diffusing fluorescent diffusing acid formation
(test of) of
glucose aerobically anaerobic fructose aerobic ASS glucose xylose
trehalose
ethanol gas formation from
glucose
ONPG.
Education
arginine dihydrolase lysine decarboxylase
An example of a stable descendent of the microorganism NK 13, which does not decompose, but introduces a lactic carnitine and grows on betaine, L-glutamate and crotonobetaine, L-glutamate and butyrobetaine, glutamate and L-carnitine is the strain NK 1331. a spontaneously and well growing colony of mutants from the surface of a dense
Description of Agrobacterium NK 1331 strain (DSM No. 3225):
Cell shape
Length, micron Oirin, micron Motility Flagellation
I)
Gram reactions
Controversy
Education
poly-hydroxybutyrate
oxidase
catalase growth in anaerobic
conditions
4GS
pH 5, .6
sticksEducation partially phennalanine-pleomorphic aminases
1-2ornithindecarboxy-1
0.5-0.8 leases
+ VHIS.peritrichal- Reaction Voges-Proskuera
New Education
indole
nitrite nitrite
Denitrification
+ f
Formation of levana lecithinase urease
Degradation, casein gelatin starch
4- +
Continuation of the krlonka 2
use of substrate
acetate of stratamalonate glycine anorleucine
xylose
fructose
glucose autotrophic growth
on H,
3-ketolactose stop
betaine
L-carnitine
J-butyrobetaine
crotonobetaine
L-glutamate and
| srotonebetaine
L-glutamate and
butyrobetaine
L-glutamate and
L-carnitine
+
+
-I
agar nutrient medium containing L-glutamate and 2 "-butyrobetaine, the Specified strain 08.02.85 was transferred to the society Besellscaft fiir Bio-technologische Forschung mbH, briese-bachstrabe 8, 4300, Gbttingen, Germany, deposited under DSM 3225 in the collection of Deutsche Sammlungvon Mikroorganismen (DSM).
+ +
Formation of levana lecithinase urease
Degradation, casein gelatin starch
Continuation to
on Maskey Coukey Agar
on agar SS on centrimid aha Pigments
non diffusible diffusible
fluorescent acid formation
(test of) of
glucose aerobic anaerobic fructose aerobic ASS glucose xylose
 trehalose
ethanol
Gas formation from
glucoseONPG
Education.
, arginine dihydrolase lysine decarboxylase. In order to implement the proposed method for producing L-carnitine, it is advisable to first level the preliminary culture of the microorganism in a sterilized medium with aO-ad C at pH 6-8 for 20-50 hours. This pre-culture should contain 0 1-10 wt.% -Butyrobetaine and crotobetaine, based on the reaction medium. T-Butyrobetaine or croton betaine can be used in the form of the hydrochloride salt, free internal salt or their derivatives, and nutrient media can be sown with the help of the pre-cultures prepared according to this method. The latter should have the same composition as the preliminary cultures of inoculum. The concentration of the crotonobetaine, γ-bugyrobetaine, or mixtures of these compounds subjected to the reaction in a nutrient medium is 0.1-10% by weight. Growth substrates — choline, glutamate, acetate, dimethylglycine and betaine — are also advisable to use in the concentrate. 351598
Continuing column 2 tyrosine
tween 80 DNA
esculina
Use of citrate acetate substrate
malonata
glycine
norleucine
xylose
fructose
glucose
Autotrophic growth on H2
3-ketolactose Growth on Betaine
L-carnitine
.u-butyrobetaine
crotonobetaine
L-glutamate and crotonobetaine L-glutamate and butyrobetaine L-glutamate and L-kgr-nitin
 + f
+ + +
five
0
five
0
five
Ratios corresponding to concentrations in the pre-culture.
The cells can be separated by centrifugation or filtration and used as seed for the preparation of a new culture. The resulting L-carnitine by cation-exchange chromatography is extracted from the supernatant and purified by recrystallization.
Example 1. The distribution of a microorganism decomposing crotonobetaine.
Microorganisms are extracted from the soil with a neutral solution of phosphate buffer with mixing, followed by separation of large components through filter paper. Using the mixture of bacteria obtained in this way, the nutrient Krotobetabein solution is inoculated before slight turbidity. After 9 days, clouding, due to a cesome of cell concentration, increased 90 times. As a result, crotonobetaine was no longer in solution in solution, and in it
Ammonium ions were proved for degradation. From this mixed culture, recourse to traditional {microbiological methods with the use of dense agar nutrient medium: pure cultures are prepared and decomposed into crotonobetine organisms. For further work, a culture designated Agrobactererium G 4 is selected from them. The ITOT strain grows in y-butyrobetae, b-carnitine and betaine.
Example 2. The selection of mutant resistant arnithine free of dehydrogenase arnithine.
The culture of the Agrobactereriura PS 4 strain using the Asgidin Mugenta ICR19t mutagen (5 μg / ml) in the succinate medium is subjected to a stable mugenizacki, after which the cells, in expressing cells, are mutated into a broth, then transferred to the etineic medium. The washed culture is introduced into the L-carnitational environment, and after a few hours the culture has stepped into the logarithmic phase of growth. Penicillin is added at this time.
(15 mg / mp) to D-cncloserin
0.5 mg / ml), as anti-selectivating agents, kill only growing bacteria. As a result of survival, muts accumulated that could not grow on carnitium. After 30 h, the number of live plots was reduced by 100 times. After antibiotic treatment, the culture is transferred to a betaine medium. Ultrasonic ultrasound is diluted and spread on a dense nutrient medium. Individual cells with the formation of colonies and, separately subjected to the test. As a result, the mutant Agrobactererium NK 13 is chosen. The latter is stable, does not contain carnitine dehydrogenase, and grows on betaine. Growing on betaine, dimethylglycine, khopine, glutamate or acetate, this strain turns crotonobetaine or U Fobetaine into L-carnitine and secretes it.
Example 3. A preliminary culture of the Agrobactererium NK 1 strain with a volume of 5 MP is cultivated for 32 hours at a pH of 7.0 in a vitamin-containing mineral medium containing 1 wt.% Betaine and 0.5 wt.X croton betaine chloride. This culture is seeded into the culture of the same composition.
, about
0 5
" , five
five
0
five
volume of 15 liters, which is then grown for 24 hours under the conditions indicated for the preliminary culture. Upon termination of the production of L-carnitine, cells are removed by centrifugation and then used as seed for preparing a new culture. The concentration of L-carnitine in the supernatant liquid (19.8 L) was determined by enzymatic analysis.
The content of L-carnitine in the supernatant was 4.26 mg / ml, which was 95.0% in yield. By cation-exchange chromatography, L-carnitine is recovered from the supernatant and purified by recrystallization.
Example 4. A preliminary culture of Agrobactererium NC 13 with a volume of 5 l is cultured for 32 hours at a pH of 7.0 in a vitamin-containing mineral medium (Example 1) containing 1% choline and 0.6% y-butyrobetaine chloride. This culture is sown in culture with a medium of the same composition with a volume of 15 liters, which is then B1f115 under the conditions of example t. Upon termination of the production of L-carnitine (after about 30 hours), the cells are separated by microfiltration. Cell mass is used to further obtain L-carnitine. The concentration of L-carnitine in the filtrate (19.6 L) is determined by enzymatic analysis. The content of L-carnitine in the filtrate is 5.3 mg / ml. This corresponded to an analytical yield of 97.6%, based on the amount used of 4-butyrobetaine chloride.,
Example 5. Intended for the preparation of a continuous culture, a fermenter containing 1.5 liters of a vitamin-containing mineral medium (according to Example 1) with 1.5% betaine and 1.0% y-butyrobetaine chloride was charged with 150 ml of Agrobactererium NC 13 pre-culture same-medium. After a: erobic growth for 1 to 20 hours at 30 ° C and pH 7.0, the culture reached full growth ... Then the cells were separated by centrifugation. According to the enzymatic analysis, the supernatant liquid contained 8.8 g of L-carnitine per liter of culture;
It should be noted that the amount of 0.1-10% is significant, since it is only in this case that the output increases. With quantities;
n143515912
above 10% osmotharbetaine or crotonobetaine will occur, factors
Cell growth pressure under aeration conditions to maximally this method allows to increase the maximum accumulation of the target product of L-carnitine by 15%. .e its subsequent allocation,
characterized in that
权利要求:
Claims (1)
[1]
The claims for the purpose of producing b-carnitine,
As a bacterial strain, a method for populating L-carnitine, the pre-diluent is Agrobacterium.
susceptible to the cultivation of the bacterium-4, or Agrobacterium NK 13, or
production strain on Pita-Agrobacterium NC 1331, in this case, the “tonic medium containing quality ubirobetaine or crotobetabein is administered
carbon source and nitrogen y-buty-in an amount of from 0.1 to 10.0%.
类似技术:
公开号 | 公开日 | 专利标题
SU1435159A3|1988-10-30|Method of producing l-carnitine
KR100249532B1|2000-03-15|Process for producing l-threonine with strains of e coli resistant to phenylalanine and leucine
KR100198039B1|1999-06-15|Process for producing l-glutamic acid by fermentation
JP3008565B2|2000-02-14|Method for producing L-glutamic acid by fermentation method
US4492756A|1985-01-08|Microorganisms of the genus Hyphomicrobium and process for degrading compounds wich contain methyl groups in aqueous solutions
KR100233330B1|1999-12-01|Microbiological process for the production of 6-hydroxypicolinic acid
SU1719433A1|1992-03-15|Method of l-alanine preparation
EP0082814A1|1983-06-29|Microorganisms of the genus pseudomonas and method for the decomposition of compounds containing methyl groups in aqueous solutions
US5314820A|1994-05-24|Process and microorganisms for producing single cell protein
JPH0564597A|1993-03-19|Production of riboflavin by fermentation
US4060455A|1977-11-29|Process for the microbial production of L-serine using pseudomonas Sp. DSM 672
US3939042A|1976-02-17|Process for the production of L-glutamic acid
EP0076516B1|1986-09-10|Method for fermentative production of l-proline
EP0310949B1|1993-02-10|Process for producing d-alanine
KR0146493B1|1998-08-01|Process for producing l-alanine by fermentation
EP0138526B1|1989-04-26|Method of producing l-phenylalanine by fermentation, and bacteria therefor
JP3100763B2|2000-10-23|Method for producing L-arginine by fermentation
KR910007856B1|1991-10-02|Method for producing l-glutamic acid
JP3006907B2|2000-02-07|Method for producing L-alanine by fermentation method
KR930001389B1|1993-02-27|Process for producing l-arginine
KR830001259B1|1983-06-30|Method for producing L-glutamine by microorganisms
JP2578496B2|1997-02-05|Production method of inosine by fermentation method
KR830001258B1|1983-06-30|Method for producing L-glutamine by microorganisms
KR920005975B1|1992-07-25|Method for preparation of l-glutamine
KR880001680B1|1988-09-06|Process for producing sisomycin
同族专利:
公开号 | 公开日
DE3583058D1|1991-07-11|
NO164918B|1990-08-20|
FI850781A0|1985-02-26|
CN1004146B|1989-05-10|
RO92477A|1987-09-30|
CN85101191A|1987-06-10|
RO92477B|1987-10-01|
AU585216B2|1989-06-15|
US5187093A|1993-02-16|
JPS60224488A|1985-11-08|
ES541663A0|1985-12-01|
HUT37653A|1986-01-23|
DK165191C|1993-03-01|
IL74552D0|1985-06-30|
DK138085D0|1985-03-27|
IN164247B|1989-02-04|
AU4019285A|1985-10-03|
NO164918C|1990-11-28|
ZA851959B|1985-11-27|
IE58045B1|1993-06-16|
YU50485A|1987-12-31|
YU45708B|1992-07-20|
FI86889C|1992-10-26|
DK165191B|1992-10-19|
CS222085A2|1990-07-12|
DK138085A|1985-09-30|
CS273163B2|1991-03-12|
PL252628A1|1986-02-25|
ES8602940A1|1985-12-01|
PL145712B1|1988-10-31|
DD232310A5|1986-01-22|
IE850533L|1985-09-29|
IL74552A|1988-12-30|
EP0158194A3|1987-07-22|
CA1265757A|1990-02-13|
EP0158194A2|1985-10-16|
BR8501374A|1985-11-26|
NO851261L|1985-09-30|
HU193744B|1987-11-30|
BG50282A3|1992-06-15|
FI86889B|1992-07-15|
AT64154T|1991-06-15|
EP0158194B1|1991-06-05|
FI850781L|1985-09-30|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US2313573A|1938-01-17|1943-03-09|Gen Aniline & Film Corp|Capillary active compounds and process of preparing them|
US2367878A|1939-05-04|1945-01-23|Hoffmann La Roche|Betaine esters|
NL6511804A|1964-11-30|1966-05-31|
FR1559839A|1968-01-30|1969-03-14|
ES370147A1|1968-08-29|1971-04-01|Gulf Research Development Co|A procedure to manufacture ciclopropilamin. |
US3711549A|1970-05-19|1973-01-16|Gulf Research Development Co|Process for manufacturing cyclopropylamine|
US3796632A|1971-12-10|1974-03-12|Toray Industries|Process for racemizing alpha-amino-epsilon-caprolactam|
DE2751134C2|1977-11-16|1986-04-17|Degussa Ag, 6000 Frankfurt|Process for the preparation of γ-chlorocarboxylic acid esters|
IT1142201B|1980-06-24|1986-10-08|Sigma Tau Ind Farmaceuti|PROCEDURE FOR THE ENZYMATIC PRODUCTION OF L-CARNITINA|
DE3214953A1|1982-04-22|1983-10-27|Hoechst Ag, 6230 Frankfurt|MICROBIAL POLYSACCHARIDES, METHOD FOR THE PRODUCTION THEREFOR, SUITABLE MICROORGANISMS AND USE OF THE POLYSACCHARIDES|
JPH0559709B2|1983-04-13|1993-08-31|Ajinomoto Kk|
DD221905B1|1983-11-03|1987-03-18|Univ Leipzig|PROCESS FOR THE PREPARATION OF L - CARNITINE AND ITS DERIVATIVES|
CH664374A5|1985-02-27|1988-02-29|Lonza Ag|METHOD FOR PRODUCING L-CARNITIN BY A MICROBIOLOGICAL WAY.|
IT1190280B|1986-04-24|1988-02-16|Sigma Tau Ind Farmaceuti|PROCEDURE FOR THE PREPARATION OF RANGE-BUTYROBETAIN|JPH0586188B2|1983-04-05|1993-12-10|Hamari Yakuhin Kogyo Kk|
JPH0559709B2|1983-04-13|1993-08-31|Ajinomoto Kk|
DD221905B1|1983-11-03|1987-03-18|Univ Leipzig|PROCESS FOR THE PREPARATION OF L- CARNITINE AND ITS DERIVATIVES|
JPS62275689A|1985-12-09|1987-11-30|Bio-Le Kk|Production of l-carnitine|
JPH0751071B2|1989-07-28|1995-06-05|ロンザリミテッド|Intermittent production method of L-carnitine by microbiological method|
DE4017595A1|1990-05-31|1991-12-05|Consortium Elektrochem Ind|MALTOPENTAOSE PRODUCING AMYLASES|
DE4106375A1|1991-02-28|1992-09-03|Degussa|A L-CARNITINE AMIDASE PRODUCING MICROORGANISM, L-CARNITINE AMIDASE, METHOD FOR THEIR PRODUCTION AND THEIR USE|
CN1058995C|1996-11-08|2000-11-29|江苏省微生物研究所|Enzymatic preparation of L-carnitine|
KR100255039B1|1997-07-28|2000-05-01|박영구|Process for the preparation of l-carnitine|
DE19749480A1|1997-11-08|1999-05-20|Univ Leipzig|Process for the production of L-carnitine from crotonobetaine|
AT356214T|2001-01-31|2007-03-15|Lonza Ag|MICROBIOLOGICAL PROCESS FOR THE PREPARATION OF L-CARNITINE|
US7407778B2|2002-02-07|2008-08-05|Pettegrew Jay W|Compounds, compositions and methods for treating neuropsychiatric disorders|
US7700074B2|2002-02-07|2010-04-20|Pettegrew Jay W|Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism|
US20060257842A1|2003-05-29|2006-11-16|Pettegrew Jay W|Cryopreservation media and molecules|
WO2004110963A2|2003-05-29|2004-12-23|Pettegrew Jay W|Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders|
CN101212956A|2005-07-05|2008-07-02|隆萨股份公司|Spray-drying process for producing a dry carnitine powder or granulate|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
CH160084|1984-03-29|
[返回顶部]